title: Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.
abstract: Serum samples from children immunized with a meningococcal serogroup B vaccine demonstrated potent serum bactericidal antibody activity against the hypervirulent Neisseria meningitidis serogroup W strain circulating in England. The recent introduction of this vaccine into the United Kingdom national immunization program should also help protect infants against this endemic strain.
authors.forename: Shamez N
authors.initials: SN
authors.lastname: Ladhani
authors.forename: Marzia Monica
authors.initials: MM
authors.lastname: Giuliani
authors.forename: Alessia
authors.initials: A
authors.lastname: Biolchi
authors.forename: Mariagrazia
authors.initials: M
authors.lastname: Pizza
authors.forename: Kazim
authors.initials: K
authors.lastname: Beebeejaun
authors.forename: Jay
authors.initials: J
authors.lastname: Lucidarme
authors.forename: Jamie
authors.initials: J
authors.lastname: Findlow
authors.forename: Mary E
authors.initials: ME
authors.lastname: Ramsay
authors.forename: Ray
authors.initials: R
authors.lastname: Borrow
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D003429:Cross Reactions / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology*; D009345:Neisseria meningitidis / Q000145:classification / Q000235:genetics / Q000276:immunology*; D006113:United Kingdom / Q000453:epidemiology; D014611:Vaccination
chemical_list: D000907:Antibodies, Bacterial; D022401:Meningococcal Vaccines
keywords: Bexsero; England; Menveo; Neisseria meningitidis; ST11 clonal complex; bacteria; endemic; immunization; meningitis; meningococcal W disease; meningococci; prevention; serum bactericidal antibody activity; vaccine
references.citation: Lancet. 2002 Feb 16;359(9306):582-3
references.pmid: 11867116
references.citation: J Exp Med. 2002 Jun 3;195(11):1445-54
references.pmid: 12045242
references.citation: Vaccine. 2009 Jun 24;27 Suppl 2:B20-9
references.pmid: 19477053
references.citation: Lancet Infect Dis. 2010 Dec;10(12):853-61
references.pmid: 21075057
references.citation: JAMA. 2012 Feb 8;307(6):573-82
references.pmid: 22318278
references.citation: Vaccine. 2012 May 21;30(24):3710-6
references.pmid: 22429756
references.citation: Euro Surveill. 2012 May 24;17(21). pii: 20181
references.pmid: 22687826
references.citation: Lancet Infect Dis. 2013 May;13(5):416-25
references.pmid: 23414709
references.citation: Vaccine. 2013 Oct 9;31(43):4968-74
references.pmid: 23954380
references.citation: BMJ. 2014;348:g2415
references.pmid: 24696308
references.citation: Lancet. 2014 Dec 13;384(9960):2123-31
references.pmid: 25145775
references.citation: Clin Infect Dis. 2015 Feb 15;60(4):578-85
references.pmid: 25389259
references.citation: Emerg Infect Dis. 2015 Feb;21(2):339-41
references.pmid: 25625322